What the doctor ordered: Pharma drives economic growth in Central Europe

What the doctor ordered: Pharma drives economic growth in Central Europe

Leveraging location, low costs, and strong legacy companies with a skilled labour pool, the pharmaceutical industry is a quiet success story in Central and Eastern Europe (CEE). The sector is a major contributor to exports and R&D spending in several countries, and has become a magnet for M&A deals in recent years.

Central Europe’s low-cost carriers take off

Central Europe’s low-cost carriers take off

By launching a subsidiary in Abu Dhabi, Hungary’s Wizz Air has made a statement of intent. Until recently, it was the Gulf airlines looking to invest in Central and Eastern Europe (CEE), rather than vice-versa. But Wizz Air has been able to leverage its success on the growing CEE market to look globally. Within CEE, the rise of low-cost carriers like Wizz Air is helping spur consolidation, with more successful flag carriers seeking inorganic growth and economies of scale.

Tapping into Central Europe’s LNG boom

Tapping into Central Europe’s LNG boom

Liquefied natural gas (LNG) imports have made a clear and positive impact on Central and Eastern Europe, improving energy security, lowering prices and decreasing Russian geopolitical leverage. The EU and US are backing billions of dollars of further investment from the Baltic to the Aegean, and MENA suppliers are expected to capitalise on the resulting expansion in capacity. However, there are still bottlenecks in infrastructure development and the outlook for the European gas market is uncertain. The global LNG glut has coincided with price and supply competition from Russia and Azerbaijan. Ironically, LNG exporters may be victims of their own success.